TPGS‐Transferrin Functionalized Polydopamine Nanocarriers Potentiate the Pharmacokinetics, Antioxidant, and Anti‐Inflammatory Activity of Carvacrol
Archiv der Pharmazie · 2026
DOI: 10.1002/ardp.70348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Rumi Mahata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Nanotherapeutics and Toxicology Research Laboratory, Biochemistry, Molecular Endocrinology, and Reproductive Physiology Division, Department o…. Hauptthemen laut MEDLINE: Cymenes, Nanoparticles, Antioxidants, Vitamin E. Die Arbeit nennt 48 Literaturangaben. Gefördert von: University Grants Commission, India.
Abstract (Originalsprache)
Poor aqueous solubility and rapid systemic clearance limit the therapeutic translation of carvacrol (CVC). Herein, we report the fabrication of carvacrol loaded, transferrin (Tf) and d ‐α‐tocopheryl polyethylene glycol succinate (TPGS) functionalized polydopamine nanoparticles (PDA NPs). We recently demonstrated the therapeutic efficacy of CVC‐PDA‐TPGS‐Tf against breast cancer. In the present study, we evaluated the in vivo pharmacokinetic (PK) and biodistribution analysis of this nanoconjugate in Swiss albino female mice. The results of PK and biodistribution analyses revealed markedly increased area under the curve (AUC) (1858 vs. 31,797 ng·min/mL) and maximum serum concentration ( C max ) (318 vs. 715 ng/mL), compared with free CVC. Biodistribution studies demonstrated preferential accumulation in the liver and kidneys with minimal penetration into the brain and spleen. The nanoconjugate displayed superior in vitro free radical scavenging activity against hydroxyl, superoxide, and nitric oxide species and an in vivo antioxidant effect relative to free CVC, and significantly attenuated inflammation in a murine paw edema model. Molecular docking suggested strong interactions of CVC with inflammation‐ and oxidative stress‐related protein targets, consistent with the observed bioactivity. Collectively, these results demonstrate that TPGS‐Tf‐modified PDA nanocarrier effectively modulates the biological behavior of CVC, offering a promising nanoplatform for improving the pharmacological performance of hydrophobic phenolic therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Nanotherapeutics and Toxicology Research Laboratory, Biochemistry, Molecular Endocrinology, and Reproductive Physiology Division, Department of Human Physiology, Vidyasagar University, Midnapore, West Bengal, Ind…
- Department of Chemistry and Chemical Technology, Vidyasagar University, Midnapore, West Bengal, India.
ORCID-Profile: Rumi Mahata, Piyali Bar, Sujata Maiti Choudhury
Förderung
- University Grants Commission, India
Zitieren
APA
Mahata, R., Modak, M., Malakar, R., Karan, G., Tripathi, K., Bar, P., Roy, S., & Choudhury, S. M. (2026). TPGS‐Transferrin Functionalized Polydopamine Nanocarriers Potentiate the Pharmacokinetics, Antioxidant, and Anti‐Inflammatory Activity of Carvacrol. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70348
Vancouver
Mahata R, Modak M, Malakar R, Karan G, Tripathi K, Bar P, et al. TPGS‐Transferrin Functionalized Polydopamine Nanocarriers Potentiate the Pharmacokinetics, Antioxidant, and Anti‐Inflammatory Activity of Carvacrol. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70348
BibTeX
@article{Mahata2026,
author = {Mahata, Rumi and Modak, Mrinmoyee and Malakar, Rimpa and Karan, Gouri and Tripathi, Kaustav and Bar, Piyali and Roy, Sumita and Choudhury, Sujata Maiti},
title = {TPGS‐Transferrin Functionalized Polydopamine Nanocarriers Potentiate the Pharmacokinetics, Antioxidant, and Anti‐Inflammatory Activity of Carvacrol},
journal = {Archiv der Pharmazie},
year = {2026},
doi = {10.1002/ardp.70348}
}
EUVIMED